SHL.DE

50.26

-0.95%↓

ARGX

488.1

+0.16%↑

VIE

29.64

-1%↓

BNR

64.2

-2.1%↓

GLPG

24.94

-1.97%↓

SHL.DE

50.26

-0.95%↓

ARGX

488.1

+0.16%↑

VIE

29.64

-1%↓

BNR

64.2

-2.1%↓

GLPG

24.94

-1.97%↓

SHL.DE

50.26

-0.95%↓

ARGX

488.1

+0.16%↑

VIE

29.64

-1%↓

BNR

64.2

-2.1%↓

GLPG

24.94

-1.97%↓

SHL.DE

50.26

-0.95%↓

ARGX

488.1

+0.16%↑

VIE

29.64

-1%↓

BNR

64.2

-2.1%↓

GLPG

24.94

-1.97%↓

SHL.DE

50.26

-0.95%↓

ARGX

488.1

+0.16%↑

VIE

29.64

-1%↓

BNR

64.2

-2.1%↓

GLPG

24.94

-1.97%↓

Accueil・Liste d'Actions・Sanofi SA

Sanofi SA

Fermé

Secteur Soins de santé

104.78 -0.46

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

104.78

Max

105.34

Chiffres clés
By Trading Economics
Revenu	1.1B
Ventes	916M 11B
P/E Moyenne du Secteur	24.91 103.001
BPA	1.73
Marge bénéficiaire	9.78
EBITDA	-136M 2B

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+3.32 upside

Dividendes
By Dow Jones
Prochains Résultats	25 oct. 2024

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	131B
Ouverture précédente	105.24
Clôture précédente	104.78

Score Technique

By Trading Central

Confiance

Weak Bearish Evidence

104.9 / 105.78 Support & Résistance

Sanofi SA Graphique

Actualités Associées

25 juil. 2024, 05:44 UTC

Résultats

Sanofi Raises Guidance After Profit, Sales Beat

24 juil. 2024, 10:24 UTC

Résultats

Spanish Bank Santander Raises 2024 Guidance After Earnings Beat -- Update

24 juil. 2024, 05:22 UTC

Résultats

Santander Raises 2024 Revenue Guidance After Earnings Increase

4 juil. 2024, 06:44 UTC

Acquisitions, Fusions, Rachats

Bain, Cinven Explore Joint Bid for Sanofi's Consumer Unit, Bloomberg Reports

27 juin 2024, 10:54 UTC

Principaux Mouvements du Marché

Vigil Neuroscience Shares Soar on $40 Million Sanofi Investment

15 août 2024, 08:21 UTC

Market Talk

Résultats

European Banks' Net Interest Income Momentum May Have Stalled -- Market Talk

14 août 2024, 07:07 UTC

Market Talk

Southern European Banks Have Attractive Net Interest Income Dynamics -- Market Talk

26 juil. 2024, 12:53 UTC

Market Talk

Résultats

European Banks' Earnings Season Had Another Good Start -- Market Talk

25 juil. 2024, 13:20 UTC

Résultats

AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD

25 juil. 2024, 11:46 UTC

Market Talk

Résultats

Sanofi Aims to Boost RSV Drug Supply -- Market Talk

25 juil. 2024, 11:23 UTC

Market Talk

Résultats

Sanofi Results Are Positive -- Market Talk

25 juil. 2024, 05:33 UTC

Résultats

Analysts Saw Sanofi 2Q Sales at EUR10.4B

25 juil. 2024, 05:33 UTC

Résultats

Sanofi 2Q Sales EUR10.745B

25 juil. 2024, 05:30 UTC

Résultats

Sanofi Had Seen 2024 Business Earnings Per Share Decreasing Low Single Digit at Constant Currency

25 juil. 2024, 05:30 UTC

Résultats

Sanofi Now Expects 2024 Business Earnings Per Share to Be Stable at Constant Currency

25 juil. 2024, 05:30 UTC

Résultats

Analysts Saw Sanofi 2Q Business Operating Income at EUR2.69B

25 juil. 2024, 05:30 UTC

Résultats

Sanofi 2Q Net Pft EUR1.11B

25 juil. 2024, 05:30 UTC

Résultats

Sanofi Raises 2024 View

25 juil. 2024, 05:30 UTC

Résultats

Sanofi 2Q Business Operating Income EUR2.81B

24 juil. 2024, 06:53 UTC

Market Talk

Résultats

Santander's Small Beats, Improved Outlook Should Be Well Received -- Market Talk

24 juil. 2024, 04:50 UTC

Résultats

Santander Raises 2024 Rev View

24 juil. 2024, 04:50 UTC

Résultats

Santander Fully-Loaded CET1 Ratio 12.5% at 2Q-End

24 juil. 2024, 04:48 UTC

Résultats

Santander 2Q Net Interest Income Fell 4.2%

24 juil. 2024, 04:48 UTC

Résultats

Santander 2Q Net Interest Income EUR11.47B

24 juil. 2024, 04:48 UTC

Résultats

Santander 2Q Net Pft EUR3.21B

24 juil. 2024, 04:47 UTC

Résultats

Santander 2Q Rev EUR15.67B

9 juil. 2024, 09:05 UTC

Actualités

These Stocks Are Moving the Most Today: Tesla, Corning, BP, Intel, and More -- Barrons.com

3 juil. 2024, 14:18 UTC

Acquisitions, Fusions, Rachats

GSK Will Pay Up to $1.5 Billion for CureVac's mRNA Vaccines -- Barrons.com

27 juin 2024, 10:39 UTC

Principaux Mouvements du Marché

Vigil Neuroscience Shares Soar on $40M Sanofi Investment

27 juin 2024, 06:08 UTC

Acquisitions, Fusions, Rachats

Vigil Neuroscience Is a Clinical-Stage Biotechnology Company >VIGL

Comparaison

Variation de prix

Sanofi SA prévision

Objectif de Prix

By TipRanks

3.32% hausse

Prévisions sur 12 Mois

Moyen 108.4 EUR 3.32%

Haut 125 EUR

Bas 85 EUR

Basé sur 12 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

12 ratings

Achat

Maintien

Vente

Basé sur 12 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

104.9 / 105.78Support & Résistance

Bearish events outweigh bullish events.

All events are bullish.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

EBITDA

Bénéfice d'exploitation

À Propos Sanofi SA

Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.